GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes By Ogkologos - July 13, 2026 54 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a large real-world cohort Source RELATED ARTICLESMORE FROM AUTHOR Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into More Inflamed Tumours and Improve Response EMA Recommends Extension of Therapeutic Indications for Serplulimab MOST POPULAR Study Links Breast Cancer Spread to Newly Discovered RNA Splicing Mechanism May 21, 2021 Garbage Men Finally Meet Cancer-Free Toddler After Bonding From Afar August 7, 2019 What’s Your Mantra? July 28, 2021 Recognising the essential role of clinical research nurses October 13, 2021 Load more HOT NEWS FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy A Combination of Teclistamab and Daratumumab Prolongs PFS in Patients with... Cancer Immunotherapy Drug Simultaneously Targets Two Proteins that Block Immune Response For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target
